|
Cognizant & marketRx join forces
Delivering business insights enabled by analytics
marketRx, Inc. a leading provider of analytics and related software services to global Life Sciences companies in the pharmaceuticals, biotechnology and medical devices segments, is now part of Cognizant (NASDAQ: CTSH), a leading provider of global IT and business process outsourcing services.
Cognizant strengthens its leadership
position in the Life Sciences/Biotech industry allowing
it to serve clients across all areas of the Life Sciences
value chain, from R&D, Manufacturing to the Sales
& Marketing Operations. marketRx brings capabilities
and experience in the services market with deep domain
knowledge and a proprietary IT-enabled delivery platform.
The Cognizant-marketRx combination offers
a fully integrated solution that supports the entire
spectrum of life sciences commercial operations and
allows clients to benefit from improved efficiency,
effectiveness, higher productivity and lower total cost
of operations.
This acquisition will result in a more
seamless delivery of services from customer data integration
to reporting to analytics. Cognizant builds the systems
that enable analytical decision-making, while marketRx
analytics-focused solutions provide business insights
capabilities to decision-makers.
The combined entity’s global resources,
end-to-end life sciences business and systems expertise,
together with proven outsourced delivery models enables
our clients to build stronger businesses. The Cognizant-marketRx
combination offers the best of both worlds: outsourced
business and systems support with a local consulting
presence that integrates business strategy with execution.
|
.gif){kind=spacer}
